The effect of fenofibrate on lymphocyte cytokine release in patients with impaired fasting glucose and impaired glucose tolerance: a preliminary report.

scientific article published on 22 July 2010

The effect of fenofibrate on lymphocyte cytokine release in patients with impaired fasting glucose and impaired glucose tolerance: a preliminary report. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ATHEROSCLEROSIS.2010.07.016
P698PubMed publication ID20705292

P50authorBogusław OkopieńQ57089603
Robert KrysiakQ90104244
P433issue1
P304page(s)325-328
P577publication date2010-07-22
P1433published inAtherosclerosisQ4813570
P1476titleThe effect of fenofibrate on lymphocyte cytokine release in patients with impaired fasting glucose and impaired glucose tolerance: a preliminary report
P478volume213

Reverse relations

cites work (P2860)
Q37700876Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis
Q90524410Sexual functioning and depressive symptoms in men with various types of prediabetes: a pilot study
Q35332645The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
Q46962775The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.

Search more.